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http://dx.doi.org/10.1016/j.jds.2013.0Abstract Background/purpose: This double-blinded randomized placebo-controlled study
aimed to evaluate the efficacy of 0.2% chlorhexidine containing Cervitec gel on periodontal
health during orthodontic treatment.
Materials and methods: Twenty-five patients undergoing fixed orthodontic treatment were
randomly assigned to the Cervitec (nZ 13) or control (nZ 12) groups. After clinical examina-
tion at first visit, all patients received professional prophylaxis, and 2 weeks later baseline (B)
evaluations are performed. Later, oral hygiene procedures were refrained for 3 days until Day
0, during which the participants in the Cervitec group were instructed to brush with standard
toothpaste (ST) (1  1) and Cervitec (1  1), whereas the control group received placebo
(1  1) until Day 14. Between Day 14 and Day 28, patients returned to brushing with ST
(2  1). The clinical measurements were recorded and subgingival plaque samples were
collected at first visit, B, Day 0, Day 14, and Day 28. Subgingival plaque samples were analyzed
for total bacteria, Porphyromonas gingivalis (P.g.), and Treponema denticola (T.d.) using real-
time polymerase chain reaction. The data were statistically analyzed.
Results: After receiving professional prophylaxis and oral hygiene instructions, remarkable im-
provements was seen in clinical and microbiological variables of the study. Although there was
a significant reduction in the QuigleyeHein Plaque Index (mQHI) score at Day 14 in only the
Cervitec group (P < 0.01), both the Cervitec group and the control group revealed significantof Periodontology, Faculty of Dentistry, Gazi University, 86. Sokak, Emek 06510 Ankara, Turkey.
o.com (B. O¨zdemir).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
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266 B. O¨zdemir et alreductions in the mQHI score at Day 28 compared with Day 0 (P < 0.001 and P < 0.01, respec-
tively). Intragroup and intergroup evaluations revealed no statistically significant alterations
for P.g. and T.d.
Conclusion: The present data suggested that brushing with Cervitec gel once a day has the po-
tential to reduce bacterial accumulation around teeth and fixed appliances in patients under-
going orthodontic treatment. However, within the limits of this study, Cervitec seems to have
no significant effect on total bacteria, P.g., and T.d. levels of subgingival dental plaque.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
Maintaining a good or acceptable oral hygiene is a difficult
task for patients undergoing orthodontic treatment with
fixed appliances. Previously, fixed orthodontic appliances
were associated with the development of white-spot le-
sions and impaired periodontal health due to increased
dental plaque accumulation around appliances such as
bands, braces, archwire ligation, and elastomeric ring.1,2
The rough surfaces and the presence of distinct gaps
around the bracket bases are reported to be critical sites
for bacterial plaque accumulation.1 Furthermore, following
tooth banding, increase of pocket probing depths (PDs),
decrease of anaerobe-to-facultative bacteria ratio, and
increase of black-pigmented bacteroides, Bacteroides
intermedius (Prevotella intermedia), and Actinomyces
odontolyticus species were reported.2 It was suggested that
regular advices and routine instructions in oral and fixed
appliance hygiene given to this group of patients are not
sufficient and did not completely overcome the possible
detrimental effects of plaque accumulation.3
Chlorhexidine digluconate (CHX) is a well-known cationic
bisbiguanide with powerful antimicrobial activity.4 Several
in vitro and in vivo studies have proven the efficacy of CHX
mouthrinses5,6 and 0.2% CHX was accepted as the gold
standard.4 Despite great benefits, its side effects, such as
extrinsic tooth and tongue staining, enhanced calculus for-
mation, taste aberrations, and rarely painful desquamations
of the oral mucosa, are associated with its concentrations
and duration of applications and led to the research of new
formulations as well as new treatment regimens.7e11
Gel form is one of the several different CHX formulations
that clinicians are interested in. Among the CHX gel studies,
there are only limited number of reports on the influences
and clinical importance of 0.2% CHX gel. Lander et al12 re-
ported that even a single irrigation of 0.2% CHX gel had a
marked effect in decreasing the percentage of spirochaetes
and motile bacteria at sites with moderate to advanced
periodontal disease. Vianna et al13 showed that 0.2%CHX gel,
in vitro, eliminated Porphyromonas endodontalis, Porphyr-
omonas gingivalis (P.g.), and P. intermedia in 15 seconds.
The CHX gel at 0.2% concentration has also been reported for
reducing pain after oral mucosal biopsy14 and removal of
mutans streptococci infection in preschool children.15
In this study, we aimed to evaluate the effect of 0.2%
CHX containing Cervitec gel on periodontal health by
investigating the clinical and microbiological parameters on
patients undergoing orthodontic treatment with fixed or-
thodontic appliances.Methods and materials
Patient selection
Twenty-five patients (mean age: 15.24 years; range: 10e24
years) with at least 20 teeth present, who have been un-
dergoing fixed orthodontic treatment at Gazi University
Faculty of Dentistry were randomly assigned to age- and
sex-matched two groups, namely, the Cervitec gel group
(Ivoclar Vivadent AG, Liechtenstein) (nZ 13) or the control
group (n Z 12). The patients had different malocclusions,
and all have been undergoing fixed orthodontic treatment
for at least 6 months. Roth straight wire brackets (0.018
in.  0.025 in. slot; GAC International Inc., Bohemia, NY,
USA) were placed on both the upper and the lower jaw of
all patients. All were at the end of the leveling stage with
0.016  0.022 inch or 0.017  0.022 inch stainless steel
archwires placed on both arches.
Individuals did not reveal any sign of periodontal
destruction at the clinic and during a radiographic exami-
nation. Patients were excluded if they had received peri-
odontal therapy, antibiotics, or an antimicrobial product in
the previous 3 months. All of the patients were systemically
healthy and patients with any diagnosed systemic disease
and condition that might interfere with the results of our
study were also excluded. All of the participants were
nonsmokers. The study was performed in accordance with
the Helsinki Declaration of 1975, as revised in Tokyo 2004.
The study protocol has been reviewed and approved by the
Ethical Board of Gazi University School of Medicine, and all
participating adult patients and parents of minors were
asked to give an informed written consent to participate,
after a thorough explanation of the safety and potential
efficacy of Cervitec gel, and the probability of receiving
Cervitec or placebo gel.
Study design
This was a double-blinded study, characterizing a random-
ized placebo-controlled trial. The study protocol is summa-
rized in Fig. 1. During their first visits, before the professional
prophylaxis, clinical periodontal parameters of the patients
were recorded and subgingival plaque samples were
collected. Later, all patients received professional prophy-
laxis and were given detailed oral hygiene instructions as
well as the same type of standard toothpastes (STs; Colgate,
Istanbul, Turkey) and toothbrushes (Banat, Istanbul,
Turkey). The patients were instructed to brush their teeth
two times a day with modified Bass technique. Patients
(14 days) (3 days)
Figure 1 Study protocol.
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visits. Two weeks after the first visit, baseline (B) clinical
indices and subgingival plaque samples were re-collected.
They were asked to refrain from all oral hygiene pro-
cedures for 3 days to aid in plaque accumulation. Later,
patients were randomly assigned by a single researcher
(B.B.T, by toss of a coin) to either the Cervitec group (nZ 13)
or the control group (n Z 12). The Cervitec group received
Cervitec gel, whereas the control group received placebo
gel. Patients and other researchers did not know which gel
had been delivered to each patient.While the Cervitec group
received 0.2% CHX (w/w) and 900 ppm sodium fluoride con-
taining Cervitec gel, the control group received placebo gel,
whichwill be used once a day during tooth brushing, and both
the groupswere advised to continue brushing once a daywith
a small pea-sized regular toothbrush. The recommended
amount of Cervitec and placebo gel to be used was a full-
toothbrush head coverage of the standard toothbrushes
provided to all patients. Two weeks later, both groups were
asked to brush their teeth two times a day with the previ-
ously provided STs. Clinical indices and subgingival plaque
samples were repeated at Days 14 and 28.
Subgingival plaque sample collection and bacterial
DNA isolation
In each patient, first maxillary premolars with bracket (right
premolar if the patient was left handed) were selected as the
representative teeth. Microbiological sampling was per-
formed at B, Day 0, 14, and 28. After removal of supragingival
plaque with sterile curettes, the sampling sites of the repre-
sentative teeth and the adjacent teeth were gently washed,
air dried, and isolated with sterile cotton rolls. Sterile paper
points (number 40)were inserted for 20 seconds in the gingival
crevice and then placed into sterile tubes and stored at
20C. Paper points were dipped in bead suspension and
agitated by vortexing. The supernatants were cleared from
cellular debris andmost proteins, and loaded into silicamatrix
spin columns. After the washing step, DNA was eluted by
DNase- and RNase-free water (UltraClean Microbial DNA
Isolation Kit; MO BIO Laboratories Inc., Carlsbad, CA, USA).
Clinical parameters
Full-mouth clinical indices and clinical indices of sampled
sites were recorded at the first visit, B, Days 0, 14, and 28by two previously calibrated examiners (B.O¨. and S‚.B). The
clinical examination included modification of the Qui-
gleyeHein Plaque Index (mQHI)16 with the use of 0.2%
erythrosine disclosing agent, gingival index (GI),17 PD,
clinical attachment level (CAL), and bleeding on probing
(BOP). The measurements were made at six sites per tooth
(mesiovestibular, midvestibular, distovestibular, mesiolin-
gual, midlingual, distolingual) using the Williams peri-
odontal probe calibrated in millimetres (Nordent
Manufacturing Inc., Elk Grove Village, IL, USA).
Quantitation of bacterial load using real-time PCR
Paper-point DNA isolates were used as template DNA in
bacterial load quantitation reactions. For each sample,
three real-time PCRs were set to assess the total bacterial,
P.g., and Treponema denticola (T.d.) recombinant DNA
(rDNA) copy numbers. In each real-time PCR, the relevant
series of quantification standards of P.g. ATCC 33277, T.d.
ATCC 35405, and Escherichia coli JM109 (E. coli) bacterial
culture suspensions were run along with the samples, in
order to calculate absolute target DNA copy number in the
samples. The reaction tubes contained 1  TaqMan Uni-
versal PCR Master Mix (Applied Biosystems, Foster City, CA,
USA), 0.5 mM of forward and reverse primers, 0.2 mM of
fluorescent-tagged 50 hydrolysis probe and 2 mL of sample or
standard DNA. The primer and probe sets for total bacterial
and specific pathogen rDNA copy number quantification are
given in Table 1. Real-time PCRs were carried using fluo-
rometric thermal cycling real-time device (LightCycler 480;
Roche Molecular Systems, Alameda, CA, USA). Data analysis
was performed using the real-time PCR device software. At
the end of each reaction, the CtDNA copy number curve of
quantification standards was analyzed and R2 value was
calculated. Absolute DNA copy numbers of samples were
calculated using the CtDNA copy number curve of the
standards.
Statistical analysis
Statistical analysis was performed using SPSS version 15.0.
Using ShapiroeWilk normality test, the distribution of
data was tested for normality before the analysis. All
data were expressed as mean  standard deviation.
Test of significance was two tailed and P < 0.05 was
considered statistically significant. Friedman test was
Table 1 Primer and probes used in the study.
Porphyromonas gingivalis rDNA
Pg16SF 50-TCGGTAAGTCAGCGGTGAAAC-30
Pg16SR 50-ATGGCAAGCTGCCTTCGCAAT-30
Pg16SP (probe) 50-FAM-CTCAACGTTCAGCCTGCCGT
TGAAA-TAMRA-30
Treponema denticola rDNA
Td16SF 50-GAATGTGCTCATTTACATAAAGGT-30
Td16SR 50-GATACCCATCGTTGCCTTGGT-30
Td16SP (probe) 50-FAM-ATGGGCCCGCGTCCCATTAG
CT-TAMRA-30
Universal bacterial rDNA
Uni152F 50-CGCTAGTAATCGTGGATCAGAATG-30
Uni220R 50-TGTGACGGGCGGTGTGTA-30
Uni177T (probe) 50-FAM-CACGGTGAATACGTTCCCGGG
C-TAMRA-30
rDNA Z recombinant DNA.
268 B. O¨zdemir et alused to determine differences between groups over time.
Time comparisons within groups were tested by Cochran
Q test.Results
A total of 13 patients who have been undergoing fixed or-
thodontic treatment (five males and eight females with a
mean age 15.46  2.85 years, between 13 and 21 years) and
12 patients for control group (six males and six females with
a mean age of 15.17  3.30 years, between 11 and 23 years)
were included in this study. All patients completed the
study, with no soft tissue exfoliation or interference on
taste. The descriptive measurements of clinical indices are
summarized in Table 2.Table 2 The mean and standard deviations of clinical indices o
Clinical indices Groups First visit Bas
mQHI (scores from 0 to 5) Cervitec 2.69 (0.75)a,b 2.1
Control 2.46 (1.10) 1.3
GI (scores from 0 to 3) Cervitec 0.63 (0.62) 0.3
Control 0.90 (0.56)g 0.4
PD (mm) Cervitec 2.11 (0.47) 2.0
Control 2.45 (1.53) 2.0
CAL (mm) Cervitec 2.11 (0.47) 2.0
Control 2.45 (1.53) 2.0
BOP (%) Cervitec 7.69 (21.37) 2.0
Control 16.67 (28.87) 2.2
BOP Z bleeding on probing; CAL Z clinical attachment level; GI Z g
depth.
a Normally distributed data are expressed as means and standard d
b For mQHI, the differences were significant between first visit and
c For mQHI, the differences were significant between Day 0 and Da
d For mQHI, the differences were significant between Day 0 and Da
e The differences were significant between baseline and Day 0 (P <
f The differences were significant between Day 0 and Day 28 (P < 0
g For GI, the differences were significant between first visit and DaClinical findings
The periodontal indices of the sampled sites improved after
periodontal prophylaxis and renewal of oral hygiene in-
structions from first visit to B (Table 2). Significant re-
ductions were detected for mQHI scores of the Cervitec
group from first visit to Day 28 (P < 0.05), Day 0 to Day 14
(P < 0.01), and Day 28 (P < 0.001). At the control group, a
statistically significant reduction was found from B to Day
0 (P < 0.01) and Day 0 to Day 28 (P < 0.001). Considering GI
scores of the sampled sites, remarkable reductions of GI
scores was seen in both the groups; however, only statis-
tically significant alteration was seen in the control group
from first visit to Day 28 (P < 0.05). Sampled site, PD, CAL,
and BOP results revealed no significant alterations in both
groups and between the two groups.
Microbiological findings
The mean values of the total bacteria counts are shown for
all examined time intervals in Fig. 2. The mean bacterial
counts for P.g. and T.d. are shown in Figs. 3 and 4,
respectively. Considering real-time PCR quantitative anal-
ysis of the total bacteria, P.g., and T.d., no statistically
significant difference was detected between groups or
sampling periods in this study.
Discussion
To our knowledge, this study appears to be the first to
evaluate the short-term clinical and microbiological in-
fluences of 0.2% CHX and 900 ppm sodium fluoride con-
taining Cervitec gel on patients undergoing fixed
orthodontic treatment at least for 6 months.
The present data revealed that from first visit to B,
periodontal prophylaxis and oral hygiene instructionsf the sampled sites.
eline Day 0 Day 14 Day 28
2 (0.92) 3.04 (0.86)c,d 1.73 (0.86)c 1.54 (0.99)b,d
7 (0.68) e 2.77 (0.60)e,f 1.67 (0.81) 1.42 (0.82) f
5 (0.38) 0.44 (0.37) 0.37 (0.35) 0.29 (0.32)
8 (0.52) 0.63 (0.46) 0.29 (0.37) 0.21 (0.30)g
6 (0.55) 2.26 (0.49) 2.02 (0.51) 1.97 (0.82)
0 (0.65) 2.01 (0.51) 2.19 (0.67) 2.22 (0.57)
6 (0.55) 2.24 (0.46) 2.22 (0.50) 1.97 (0.82)
0 (0.65) 2.01 (0.51) 2.19 (0.67) 2.22 (0.57)
8 (7.22) 0.00 (0.00) 1.92 (6.93) 1.92 (6.93)
7 (7.54) 4.67 (9.65) 4.17 (9.73) 0.00 (0.00)
ingival index; mQHI Z QuigleyeHein Plaque Index; PD Z pocket
eviations. Friedman test was used for comparisons.
Day 28 (P < 0.05).
y 14 (P < 0.01).
y 28 (P < 0.001) in the Cervitec group.
0.01).
.01) in the control group.
y 28 (P < 0.05) in the control group.
Figure 2 Comparison of the Cervitec and control groups’
real-time PCR quantification of total bacteria in subgingival
plaque. The data are expressed as mean and standard
deviation.
Figure 4 Comparison of the Cervitec and control groups’
real-time PCR quantification of Treponema denticola in sub-
gingival plaque. The data are expressed as mean and standard
deviation.
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reduced total bacteria, P.g., and T.d., although the dif-
ferences were not always statistically significant. This
result confirms the importance of repeated periodontal
treatment and oral hygiene instructions and motivation
caused by the frequent clinicianepatient contact.
When 2 weeks of once-a-day brushing with Cervitec was
compared with placebo, clinical indices revealed that pla-
que accumulation reduced significantly only in the Cervitec
group during the experimental period from Day 0 to Day 14
(P < 0.01). Nevertheless in the control group, reduction
was significant only at Day 28 (P < 0.01). In contrast to our
findings, Soukoulis and Hirsch18 reported that after 4 weeks
of brushing with 0.2% CHX gel two times a day, there were
better plaque score changes in the CHX group compared
with the placebo group, but the difference was not signif-
icant. They also reported reductions in GI and papillary
bleeding index after 4 weeks, with only the GI reductions
being significant.18 In contrast to our study, Soukoulis andFigure 3 Comparison of the Cervitec and control groups’
real-time PCR quantification of Porphyromonas gingivalis in
subgingival plaque. The data are expressed as mean and
standard deviation.Hirsch18 recruited patients between 18 and 60 years of age
with moderate to severe gingivitis, and poor compliance in
gel usage was reported among patients.
Total bacteria, P.g., and T.d. quantitatively increased as
expected during 3 days of plaque accumulation but no
significant difference was found between groups. Although
both P.g. and T.d. increased from Days 0 to Day 14 in the
control group, reductions were noteworthy at the Cervitec
group during the same period. Moreover, when the B and
Day 14 data are considered, it can be suggested that daily
use of Cervitec helps to downregulate P.g. and T.d. colo-
nization at the subgingival microbial dental plaque.
Although the effect of CHX against the subgingival spiro-
chetes has been reported to be only moderate or weak and
often of short duration,19 our data supported the previous
reports20,21 about important effects of CHX on T.d. and P.g.
The CHX kills microorganisms by compromising the integrity
of the cell membrane and reported to require a shorter
exposure time than, for example, a bacteriostatic agent,
such as tetracycline, which inhibits protein synthesis.22 Our
present data are also in agreement with some previous
studies that reported the effectiveness of CHX in control-
ling plaque in different groups and by different ways of
application.13,23e26
After cessation of Cervitec and placebo gel use (from
Day 14 to Day 28), both bacterial counts were increased in
the Cervitec group, while P.g. reduced and T.d. continued
to increase with a milder pattern in the control group. The
number of total bacteria increased in both groups. How-
ever, none of those changes were statistically significant.
Previously, it was stated that CHX had an affinity for hy-
droxyapatite, tooth surfaces, and salivary mucins, and that
the adsorbed CHX is released slowly when the concentra-
tion in the environment is low.27 It was also suggested that
when it is applied by tooth brushing, it can be carried to the
binding sites around the teeth and oral cavity, from where a
slow release occurs.27,28 Within the limits of our study, even
if the slow release of CHX occurred after cessation of daily
brushing with Cervitec gel, our data failed to present some
270 B. O¨zdemir et alnoteworthy clinical or microbiological effects of CHX after
cessation. Present results revealed that there were no
differences in the means of P.g. and T.d. between two
groups after cessation of daily Cervitec gel use. However, it
should also be considered that examining the effects of CHX
gel depends on numerous variables, such as different con-
centrations, formulations, administration time, and
forms.29,30 Because of these constraints, it is hard to make
direct comparisons among studies. Previously, it was stated
that the effects of CHX gel also depend on the skill of pa-
tients to deliver the gel to the appropriate areas of the
mouth.28 Saxen et al29 suggested that CHX gel does not
easily penetrate to the areas other than its site of
application.
There are only limited number of studies on the in-
fluences and clinical importance of 0.2% CHX gel. Vianna
et al13 evaluated in vitro antimicrobial activity of 0.2%, 1%,
and 2% CHX in gel and liquid formulations against several
planktonic bacteria including P.g., and reported that all
tested formulations were able to eliminate P.g. after 15
seconds. By contrast, in our study, patients used 0.2% CHX
containing Cervitec gel once a day during brushing for 2
minutes, but no statistically significant alteration at P.g.
and T.d. levels within subgingival plaque could be detec-
ted. This disparity between two results may be due to the
different natures of sessile cells of biofilm and planktonic
cells. As different from Vianna et al, in our study we in vivo
examined clinical and microbial effects of CHX against P.g.
and T.d. within subgingival plaque biofilm. It is well
described before that each biofilm bacterium lives in a
customized microniche in a complex microbial community
so that it differs fundamentally from a planktonic cell of
the same species.31,32 Previously, it was reported that
planktonic bacteria are more susceptible to the effects of
antibiotics and to environmental and host factors, whereas
sessile bacteria are able to resist or evade such destructive
factors by forming aggregates, altering their physiology,
and taking advantage of deficiencies in the host clearance
mechanisms.31e33
In the present study, we evaluated quantitative changes
within subgingival microflora by daily Cervitec gel use, but
we did not examine whether their pathogenic properties
are affected. Ostela et al34 examined the effects of
CHXesodium fluoride gel on salivary mutans streptococci
and reported that the number of bacteria reduced after gel
application and adherence of mutans streptococci was also
reduced. In future studies, not only quantitative and
qualitative alterations in dental plaque, but also the effects
of Cervitec on pathogenic properties of specific periodontal
bacteria should be addressed.
In this study, GI was used to evaluate clinical gingival
inflammation. Although some significant reductions were
detected in each group between observation periods, no
significant alterations were detected between the Cervitec
and control groups. To obtain more information about al-
terations of the gingival inflammation, in future studies,
inflammatory and proinflammatory cytokine levels within
gingival crevicular fluid should be also examined.
To sum up, in this study, both oral hygiene practices
ended up with successful clinical results, and the present
data suggested that daily use of Cervitec gel appears to
have a considerable potential at reducing dental plaqueaccumulation around teeth and maintaining good oral hy-
giene in patients wearing fixed orthodontic appliances.
Moreover, the clinical and the bacteriological findings of
this study seem to be in line. Even though no statistical
significance could be detected between groups or time in-
tervals for quantitative bacterial alterations, P.g. and T.d.
reductions seen at the experimental period within sub-
gingival dental plaque were notable. Further studies con-
ducted with larger adult groups, possibly with the history of
periodontal disease and longer research periods will clarify
the potential of daily Cervitec use within oral hygiene
measures.
Conflicts of interest
The authors have no conflicts of interest relevant to this
article.Acknowledgments
This study was funded by Gazi University Research Grant
03/2006-29.References
1. Sukontapatipark W, el-Agroudi MA, Selliseth NJ, Thunold K,
Selvig KA. Bacterial colonization associated with fixed ortho-
dontic appliances. A scanning electron microscopy study. Eur J
Orthod 2001;23:475e84.
2. Diamanti-Kipioti A, Gusberti FA, Lang NP. Clinical and micro-
biological effects of fixed orthodontic appliances. J Clin
Periodontol 1987;14:326e33.
3. Hagg U, Kaveewatcharanont P, Samaranayake YH,
Samaranayake LP. The effect of fixed orthodontic appliances on
the oral carriage of Candida species and Enterobacteriaceae.
Eur J Orthod 2004;26:623e9.
4. Schiott CR, Briner WW, Lo¨e H. Two year oral use of chlorhex-
idine in man. II. The effect on the salivary bacterial flora.
J Periodontal Res 1976;11:145e52.
5. Mackenzie IC, Nuki K, Lo¨e H, Schio¨tt CR. Two years oral use of
chlorhexidine in man. V. Effects on stratum corneum of oral
mucosa. J Periodontal Res 1976;11:165e71.
6. Schiio¨tt CR, Lo¨e H, Briner WW. Two year oral use of chlor-
hexidine in man IV. Effect on various medical parameters.
J Periodontal Res 1976;11:158e64.
7. Ernst CP, Prockl K, Willershausen B. The effectiveness and side
effects of 0.1% and 0.2% chlorhexidine mouthrinses: a clinical
study. Quintessence Int 1998;29:443e8.
8. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative
antiplaque and antigingivitis effectiveness of a chlorhexidine
and an essential oil mouthrinse: 6-month clinical trial. J Clin
Periodontol 2004;31:878e84.
9. Flo¨tra L, Gjermo P, Ro¨lla G, Waerhaug J. Side effects of chlor-
hexidine mouth washes. Scand J Dent Res 1971;79:119e25.
10. Cumming BR, Lo¨e H. Optimal dosage and method of delivering
chlorhexidine solutions for the inhibition of dental plaque.
J Periodontal Res 1973;8:57e62.
11. Jenkins S, Addy M, Newcombe R. Comparison of two
commercially available chlorhexidine mouthrinses: II. Effects
on plaque reformation, gingivitis, and tooth staining. Clin Prev
Dent 1989;11:12e6.
12. Lander PE, Newcomb GM, Seymour GJ, Powell RN. The anti-
microbial and clinical effects of a single subgingival irrigation
Evaluation of Cervitec gel effect on periodontal health 271of chlorhexidine in advanced periodontal lesions. J Clin
Periodontol 1986;13:74e80.
13. Vianna ME, Gomes BP, Berber VB, Zaia AA, Ferraz CC, de Souza-
Filho FJ. In vitro evaluation of the antimicrobial activity of
chlorhexidine and sodium hypochlorite. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod 2004;97:79e84.
14. Lo´pez-Jornet P, Camacho-Alonso F, Martinez-Canovas A. Clin-
ical evaluation of polyvinylpyrrolidone sodium hyaluronate gel
and 0.2% chlorhexidine gel for pain after oral mucosa biopsy: a
preliminary study. J Oral Maxillofac Surg 2010;68:2159e63.
15. Law V, Seow WK. A longitudinal study of 0.2% chlorhexidine gel
for removal of mutans streptococci infection in preschool
children. Aust Dent J 2007;52:26e32.
16. Kossack C, Jost-Brinkmann PG. Plaque and gingivitis reduction
in patients undergoing orthodontic treatment with fixed
appliances-comparison of toothbrushes and interdental
cleaning aids. A 6-month clinical single-blind trial. J Orofac
Orthop 2005;66:20e38. [Article in English, German].
17. Loe H, Silness J. Periodontal disease in pregnancy. I. Preva-
lence and severity. Acta Odontol Scand 1963;21:533e51.
18. Soukoulis S, Hirsch R. The effects of a tea tree oil-containing gel
on plaque and chronic gingivitis. Aust Dent J 2004;49:78e83.
19. Fiehn NE. Susceptibility of small-sized oral spirochetes to eight
antibiotics and chlorhexidine. Acta Pathol Microbiol Immunol
Scand B 1987;95:325e9.
20. Ma¨kinen PL, Ma¨kinen KK, Syed SA. Role of the chymotrypsin-
like membrane-associated proteinase from Treponema denti-
cola ATCC 35405 in inactivation of bioactive peptides. Infect
Immun 1995;63:3567e75.
21. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T,
Ebisu S. Effects of chlorhexidine, minocycline, and metroni-
dazole on Porphyromonas gingivalis strain 381 in biofilms.
J Periodontol 2003;74:1647e51.
22. Quirynen M, Teughels W, De Soete M, van Steenberghe D.
Topical antiseptics and antibiotics in the initial therapy of
chronic adult periodontitis: microbiological aspects. Perio-
dontol 2000 2002;28:72e90.23. Addy M, Bates JF. The effect of partial dentures and chlor-
hexidine gluconate gel on plaque accumulation in the absence
of oral hygiene. J Clin Periodontol 1977;4:41e7.
24. Borutta A, Heinrich R, Senkel H. Effect of chlorhexidine in the
form of an 0.2% solution and a 1% gel upon the gingiva and the
state of oral hygiene of schoolchildren (author’s transl.). Zahn
Mund Kieferheilkd Zentralbl 1980;68:322e6. [Article in
German].
25. Francis JR, Addy M, Hunter B. A comparison of three delivery
methods of chlorhexidine in handicapped children. II. Parent
and house-parent preferences. J Periodontol 1987;58:456e9.
26. Lie T, Enersen M. Effects of chlorhexidine gel in a group of
maintenance-care patients with poor oral hygiene. J Perio-
dontol 1986;57:364e9.
27. Ro¨lla G, Lo¨e H, Schiott CR. The affinity of chlorhexidine for
hydroxyapatite and salivary mucins. J Periodontal Res 1970;5:
90e5.
28. Jones CG. Chlorhexidine: is it still the gold standard? Perio-
dontol 2000 1997;15:55e62.
29. Saxen L, Niemi ML, Ainamo J. Intraoral spread of the antimi-
crobial effect of a chlorhexidine gel. Scand J Dent Res 1976;84:
304e7.
30. Usher PJ. Oral hygiene in mentally handicapped children.
A pilot study of the use of chlorhexidine gel. Br Dent J 1975;
138:217e21.
31. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-
Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49:
711e45.
32. Overman PR. Biofilm: a new view of plaque. J Contemp Dent
Pract 2000;1:18e29.
33. Prosser BL, Taylor D, Dix BA, Cleeland R. Method of evaluating
effects of antibiotics on bacterial biofilm. Antimicrob Agents
Chemother 1987;31:1502e6.
34. Ostela I, Tenovuo J, So¨derling E, Lammi E, Lammi M. Effect of
chlorhexidine-sodium fluoride gel applied by tray or by tooth-
brush on salivary mutans streptococci. Proc Finn Dent Soc
1990;86:9e14.
